Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M71,685Revenue $M6,932Net Margin (%)27.8Z-Score15.7
Enterprise Value $M70,414EPS $7.8Operating Margin %38.4F-Score8
P/E(ttm))28.7Cash Flow Per Share $7.4Pre-tax Margin (%)38.2Higher ROA y-yY
Price/Book6.910-y EBITDA Growth Rate %25.7Quick Ratio1.9Cash flow > EarningsY
Price/Sales8.05-y EBITDA Growth Rate %20.1Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %51.4ROA % (ttm)20.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)27.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M236ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 303.55-8%New holding, 80000 sh.80,000
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 303.55-8%New holding, 31391 sh.31,391
BIIBRay Dalio 2014-09-30 Buy $299.29 - $346.3
($329.79)
$ 303.55-8%New holding, 1646 sh.1,646
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 303.55-8%Reduce -58.26%233,600
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 303.551%Add 386.61%88,885
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 303.551%Add 41.76%8,632
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 303.551%Sold Out0
BIIBAndreas Halvorsen 2014-06-30 Sold Out -0.5%$274 - $320.13
($300.74)
$ 303.551%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 303.551%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 303.551%Sold Out0
BIIBJohn Burbank 2014-06-30 Sold Out -0.01%$274 - $320.13
($300.74)
$ 303.551%Sold Out0
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 303.55-4%New holding, 116000 sh.116,000
BIIBAndreas Halvorsen 2014-03-31 Buy 0.5%$273.518 - $351.94
($316.4)
$ 303.55-4%New holding, 388900 sh.388,900
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 303.55-4%New holding, 3931 sh.3,931
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 303.55-4%New holding, 7500 sh.7,500
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 303.55-4%New holding, 6089 sh.6,089
BIIBJohn Burbank 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 303.55-4%New holding, 783 sh.783
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 303.55-4%Add 796.27%18,266
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 303.55-4%Reduce -32.19%599,400
BIIBRay Dalio 2014-03-31 Sold Out -0.04%$273.518 - $351.94
($316.4)
$ 303.55-4%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ken Heebner 2014-09-3080,0000.030.75New Buy
BIIB Joel Greenblatt 2014-09-3031,3910.010.1New Buy
BIIB Ray Dalio 2014-09-301,64600New Buy
BIIB Mario Gabelli 2014-09-304,63500.01+11.02%
BIIB Frank Sands 2014-09-304,952,0962.14.1+1.24%
BIIB Ron Baron 2014-09-308,61300.01-0.22%
BIIB PRIMECAP Management 2014-09-3017,216,6317.296.1-0.24%
BIIB Ken Fisher 2014-09-3078,4570.030.06-11.73%
BIIB Vanguard Health Care Fund 2014-09-30233,6000.10.2-58.26%
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Holtzman Steven HEVP Corporate Development 2014-11-11Sell1,750$330-8.02view
SCANGOS GEORGE ACEO 2014-11-03Sell1,128$320.78-5.37view
Holtzman Steven HEVP Corporate Development 2014-10-01Sell1,750$330.97-8.28view
SCANGOS GEORGE ACEO 2014-10-01Sell1,127$330.97-8.28view
SCANGOS GEORGE ACEO 2014-09-02Sell1,128$345.47-12.13view
SCANGOS GEORGE ACEO 2014-08-01Sell1,128$332.93-8.82view
SCANGOS GEORGE ACEO 2014-07-16Sell12,316$312.37-2.82view
Posner Brian SDirector 2014-06-20Sell605$315-3.63view
Posner Brian SDirector 2014-06-13Sell700$310.5-2.24view
SCANGOS GEORGE ACEO 2014-06-02Sell484$318.93-4.82view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
    Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 
    Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 
    A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
    Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
    Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS Feb 09 2014 
    Weekly CFO Sells Highlight: CSOD, UTX, MEMS, SBAC, BIIB Sep 22 2013 
    PRIMECAP Trims Top Biotechs and More Aug 30 2013 


    More From Other Websites
    Finding a Margin of Safety in a Fully Valued Market Nov 21 2014
    Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany Nov 21 2014
    Zacks Industry Outlook Highlights: Mylan, Sanofi, Amgen, Biogen, and Actavis Nov 20 2014
    Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference Nov 19 2014
    UPDATE: Credit Suisse Reiterates On Biogen Idec On Gilenya PPMS Risk Nov 19 2014
    Argos Therapeutics (ARGS) Jumps: Stock Gains 7.4% Nov 19 2014
    Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% Nov 18 2014
    Lightning Round: Wal-Mart is better than this Nov 17 2014
    Cramer: This stock has begun to turnaround Nov 17 2014
    Biotech Stocks Hit: Stock Market To See New Leaders? Nov 14 2014
    US STOCKS-Wall St posts gains for 4th week; ends flat for day Nov 14 2014
    All in all, another solid week for U.S. equities... Nov 14 2014
    Stocks Drift Lower As Biotechs Tumble Nov 14 2014
    US STOCKS-Wall St inches lower with healthcare shares Nov 14 2014
    Stocks Mixed; Amazon Jumps On Book Deal Nov 14 2014
    The Bull/Bear Breakdown On Biogen Idec Nov 13 2014
    Dynavax's Heplisav Phase III Trial Recommended to Continue Nov 11 2014
    Orexigen (OREX) Worth Watching: Stock Soars 33.3% Nov 11 2014
    Shire CEO Looks Ahead To Independent Future Nov 10 2014
    Intercept Pharmaceuticals' Shares Crash on FLINT Results Nov 10 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK